The cost to develop a single drug from invention to pharmacy shelves is estimated around $2.7 billion, according to Forbes in 2017. Even with this staggering number, 90% of drugs don’t make it to market because they are deemed unsafe or ineffective. We hope to change this. As a team, Syroto Bioprinters offers affordable, easy to use, and efficient printers that can print 3D cell matrices used for drug development. More realistic cell models allow for better representation of the human body and allow for accurate results from each drug regarding its effects on patients.
Syroto Bioprinters is developing cutting-edge customizable 3D bioprinters designed to fast track pharmaceutical development. It’s modular design and rotating print head platform allow for interchangeable, material-specific syringe heads that can accommodate a variety of customer applications for diverse printing needs.
Discovery Made Easy
Fast tracking pharmaceuticals means opening doors to more meaningful medicine
2400 Engineering Hall
University of California, Irvine
Irvine, CA 92691